These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 23557758)

  • 1. Complex networks of multiple factors in the pathogenesis of uterine leiomyoma.
    Islam MS; Protic O; Stortoni P; Grechi G; Lamanna P; Petraglia F; Castellucci M; Ciarmela P
    Fertil Steril; 2013 Jul; 100(1):178-93. PubMed ID: 23557758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenomic and enhancer dysregulation in uterine leiomyomas.
    Mlodawska OW; Saini P; Parker JB; Wei JJ; Bulun SE; Simon MA; Chakravarti D
    Hum Reprod Update; 2022 Jun; 28(4):518-547. PubMed ID: 35199155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current understanding of somatic stem cells in leiomyoma formation.
    Mas A; Cervello I; Gil-Sanchis C; Simón C
    Fertil Steril; 2014 Sep; 102(3):613-20. PubMed ID: 24890270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MED12 mutation frequency in unselected sporadic uterine leiomyomas.
    Heinonen HR; Sarvilinna NS; Sjöberg J; Kämpjärvi K; Pitkänen E; Vahteristo P; Mäkinen N; Aaltonen LA
    Fertil Steril; 2014 Oct; 102(4):1137-42. PubMed ID: 25108465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Highly heterogeneous genomic landscape of uterine leiomyomas by whole exome sequencing and genome-wide arrays.
    Yatsenko SA; Mittal P; Wood-Trageser MA; Jones MW; Surti U; Edwards RP; Sood AK; Rajkovic A
    Fertil Steril; 2017 Feb; 107(2):457-466.e9. PubMed ID: 27889101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic and genetic landscape of uterine leiomyomas: a current view over a common gynecological disease.
    Laganà AS; Vergara D; Favilli A; La Rosa VL; Tinelli A; Gerli S; Noventa M; Vitagliano A; Triolo O; Rapisarda AMC; Vitale SG
    Arch Gynecol Obstet; 2017 Nov; 296(5):855-867. PubMed ID: 28875276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leiomyomas and genomics.
    Siristatidis C; Vogiatzi P; Polizou H; Fascilla FD; Bettocchi S
    Minerva Ginecol; 2016 Jun; 68(3):274-82. PubMed ID: 26824507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subtype-Specific Tumor-Associated Fibroblasts Contribute to the Pathogenesis of Uterine Leiomyoma.
    Wu X; Serna VA; Thomas J; Qiang W; Blumenfeld ML; Kurita T
    Cancer Res; 2017 Dec; 77(24):6891-6901. PubMed ID: 29055020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiproliferative effects by Let-7 repression of high-mobility group A2 in uterine leiomyoma.
    Peng Y; Laser J; Shi G; Mittal K; Melamed J; Lee P; Wei JJ
    Mol Cancer Res; 2008 Apr; 6(4):663-73. PubMed ID: 18403645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proinflammatory and profibrotic mediators: principal effectors of leiomyoma development as a fibrotic disorder.
    Chegini N
    Semin Reprod Med; 2010 May; 28(3):180-203. PubMed ID: 20414842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic Mechanisms Driving Uterine Leiomyoma Pathobiology, Epidemiology, and Treatment.
    Ramaiyer MS; Saad E; Kurt I; Borahay MA
    Genes (Basel); 2024 Apr; 15(5):. PubMed ID: 38790186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of microRNA-21 and programmed cell death 4 in the pathogenesis of human uterine leiomyomas.
    Fitzgerald JB; Chennathukuzhi V; Koohestani F; Nowak RA; Christenson LK
    Fertil Steril; 2012 Sep; 98(3):726-734.e2. PubMed ID: 22728051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estrogen-induced changes in IGF-I, Myb family and MAP kinase pathway genes in human uterine leiomyoma and normal uterine smooth muscle cell lines.
    Swartz CD; Afshari CA; Yu L; Hall KE; Dixon D
    Mol Hum Reprod; 2005 Jun; 11(6):441-50. PubMed ID: 15879465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extracellular matrix in uterine leiomyoma pathogenesis: a potential target for future therapeutics.
    Islam MS; Ciavattini A; Petraglia F; Castellucci M; Ciarmela P
    Hum Reprod Update; 2018 Jan; 24(1):59-85. PubMed ID: 29186429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gonadotropin-releasing hormone (GnRH) agonist leuprolide acetate and GnRH antagonist cetrorelix acetate directly inhibit leiomyoma extracellular matrix production.
    Britten JL; Malik M; Levy G; Mendoza M; Catherino WH
    Fertil Steril; 2012 Nov; 98(5):1299-307. PubMed ID: 22901846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uterine fibroids: the elephant in the room.
    Walker CL; Stewart EA
    Science; 2005 Jun; 308(5728):1589-92. PubMed ID: 15947177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymorphism of the p53 tumor suppressor gene is associated with susceptibility to uterine leiomyoma.
    Denschlag D; Bettendorf H; Watermann D; Keck C; Tempfer C; Pietrowski D
    Fertil Steril; 2005 Jul; 84(1):162-6. PubMed ID: 16009172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular characterization of uterine fibroids and its implication for underlying mechanisms of pathogenesis.
    Hoffman PJ; Milliken DB; Gregg LC; Davis RR; Gregg JP
    Fertil Steril; 2004 Sep; 82(3):639-49. PubMed ID: 15374708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uterine leiomyoma in the Eker rat: a unique model for important diseases of women.
    Walker CL; Hunter D; Everitt JI
    Genes Chromosomes Cancer; 2003 Dec; 38(4):349-56. PubMed ID: 14566855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aberrant expression of HMGA2 in uterine leiomyoma associated with loss of TSC2 tumor suppressor gene function.
    Hunter DS; Klotzbücher M; Kugoh H; Cai SL; Mullen JP; Manfioletti G; Fuhrman U; Walker CL
    Cancer Res; 2002 Jul; 62(13):3766-72. PubMed ID: 12097287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.